Sponsor Pipeline

Grand Shuyang Life Sciences (Chengdu) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07233213 An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary… Primary Immune Thrombocytopenia (ITP) Recruiting
Get alerts when Grand Shuyang Life Sciences (Chengdu) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free